Drug Price Transparency Program seeks input on prescription increases

July 26, 2024

Salem – The Oregon Division of Financial Regulation's (DFR) Drug Price Transparency Program is seeking the public's input on high prescription drug prices. Consumers are encouraged to report prescription drug price increases on DFR's website, dfr.oregon.gov/rxdrugprices.

If anyone needs help completing this form, or has questions, they can call the message line at 833-210-4560 (toll-free) and leave a message with the best time to call back. Individuals can also reach DFR by email at rx.prices@dcbs.oregon.gov.

Getting information directly from consumers will help DFR have more accurate information about how consumers are affected by high or increased costs of their prescription drugs. This will help the division inform the Oregon Legislature in DFR's annual report, which is expected to come out in December. Consumers can also view the data on the DFR website and provide stories for the annual hearing and report.

“We recognize that prescription drug costs are increasing and the impact this has on Oregonians on a daily basis," DFR Administrator TK Keen said. “Our hope is to get input from the public so we can inform policymakers and researchers alike on prescription drug costs."

###

About Oregon DFR: The Division of Financial Regulation protects consumers and regulates insurance, depository institutions, trust companies, securities, and consumer financial products and services. The division is part of the Department of Consumer and Business Services, Oregon's largest consumer protection and business regulatory agency. Visit dfr.oregon.gov and dcbs.oregon.gov.